Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Mylan announced the launch of Olmesartan Medoxomil Tablets and Olmesartan Medoxomil and Hydrochlorothiazide Tablets, the first generic versions of Daiichi Sankyo‘s Benicar and Benicar HCT.
Olmesartan Medoxomil is indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. Olmesartan Medoxomil and Hydrochlorothiazide is indicated for the treatment of hypertension to lower blood pressure; it is not indicated for the initial therapy of hypertension.
Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB). Olmesartan Medoxomil and Hydrochlorothiazide combines an ARB with a thiazide diuretic.
Olmesartan Medoxomil Tablets are available as 5mg, 20mg and 40mg strengths. Olmesartan Medoxomil and Hydrochlorothiazide Tablets are available as 20mg/12.5mg, 40mg/12.5mg, and 40mg/25mg strength tablets.
For more information call (800) RX-MYLAN or visit Mylan.com.
